Home
Faculty
Podcasts
Webcasts
FAQ Video Module
Journal Club Videos Module
Medical Review Videos Module
Publications
Digital Sponsors
Subscribe
X
Full Name
Email Address
Provider Type
Select Category
MD
DO
PA
NP
RN
MA
Dietician
Other
This field is required.
Subscribe
Reset
Podcasts
Podcasts
Category
IBS-C
Biosimilars
Cirrhosis
Hepatic Encephalopathy
MASH
PBC
CSID
IBD
Payer
Sort by
Oldest
Newest
GHAPPcast: Mental Health Issues and Symptoms Related to IBS-C
Setting Expectations When Initiating New Therapy
Diagnosing IBS With Confidence
Diagnosing EPI and Managing With The Appropriate PERT Dosing
Implementing the IBS Guideline
The Clinical Utility of Guselkumab in CD
Simplifying Access: Prior Authorization Part 1
Simplifying Access: Prior Authorization Part 2
Simplifying Access: Evolving Drug Distribution Channels
GHAPPcast: The Clinical Utility of Guselkumab in UC
GHAPPcast Part 3: Provider & Patient Support
GHAPPcast Part 2: Diagnosis and Management
Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression
GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis
GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications
GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD
Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis
Building a Sense of Urgency for PBC Patient Evaluation/Monitoring
Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy
Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy
Download the app and start using it now
Download on the
App Store
GET IT ON
Google Play
X
Install our app for the best experience!
Install Now
Home 
Faculty 
Podcasts 
Webcasts 
FAQ Video Module 
Journal Club Videos Module 
Medical Review Videos Module 
Publications 
Digital Sponsors 
